Very good. Thank you, Chair.
Thank you to all the witnesses who have joined us today. We appreciate your testimony.
I'm going to start with Dr. Bell.
I note that you are excellent at getting preclinical trials to become clinical trials and become successful. I know there was discussion when the government decided it was going to implement the PMPRB rules to change the drug approval process in Canada to make it longer and more costly. At the time, they had suggested that would have a negative impact on clinical trials, in which Canada actually punches above its weight. I wonder if that will have an influence on your situation.